Post My Press Release

Free Press Release Distribution

Author: diksha (Page 2 of 29)

Ophthalmic Equipment Market USD 44.37 Billion Revenue at CAGR of 21.2% Forecasts by 2023

Ophthalmic Equipment Market – Highlights

The market in Asia Pacific is expected to grow rapidly in the coming years. Based on a detailed study and analysis, it is found that this region has a good growth potential due to the increasing unhealthy eating habits and unhygienic conditions. Major factors driving the market are increasing geriatric population and increasing healthcare expenditure. On the other hand, low awareness in developing and underdeveloped regions regarding ophthalmic diseases may hamper the market growth during the forecast period.

Ophthalmic Equipment Market – Key Players

Some of the key players in this market are Alcon (U.S.), Bausch & Lomb (U.S.), Carl Zeiss Meditec (Germany), Johnson & Johnson (U.S.), Essilor International S.A. (France), Haag-Streit (Switzerland), Nidek (Korea), Staar Surgical (U.S.), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Hoya Corporation (Japan), Ridex Corporation (U.S.), and others.

Get Exclusive Sample Copy at https://www.marketresearchfuture.com/sample_request/5973

Ophthalmic Equipment Market – Segmentation

The global ophthalmic equipment market is segmented on the basis of product, application, and end-user.

On the basis of product, the market is segmented into vision care devices, ophthalmology surgical devices, diagnostic and monitoring devices, and others. Vision care devices a segmented into spectacles and contact lens. Contact lenses are further segmented into soft contact lenses, Rigid Gas Permeable lenses (RGP), and hybrid contact lenses. Ophthalmology surgical devices are segmented into cataract surgical devices, vitreoretinal surgical devices, refractive surgical devices, glaucoma surgical devices, ophthalmic microscopes, ophthalmic accessories, and others. Cataract surgical devices are further segmented into Intraocular Lenses (IOLS), Ophthalmic Viscoelastic Devices (OVDS), phacoemulsification devices, cataract surgical lasers, and others. The vitreoretinal surgical devices segment is further segmented into vitreoretinal packs, vitrectomy machines, photocoagulation lasers, illumination devices, vitrectomy probes, and others. The refractive surgical devices segment is further segmented into femtosecond lasers, excimer lasers, and others. Glaucoma surgical devices are further segmented into Glaucoma Drainage Devices (GDDS), and micro-invasive glaucoma surgical devices. Ophthalmic accessories are further segmented into surgical instruments and kits, ophthalmic forceps, ophthalmic spatulas, ophthalmic tips and handles, ophthalmic scissors, macular lenses, ophthalmic cannulas, and others. Diagnostic and monitoring devices are segmented into optical coherence tomography scanners, fundus cameras, perimeters/visual field analyzers, autorefractors and keratometers, ophthalmic ultrasound imaging systems, tonometers, slit lamps, phoropters, wavefront aberrometers, optical biometry systems, ophthalmoscopes, lensmeters, corneal topography systems, chart projectors, specular microscopes, retinoscopes, and others. Ophthalmic ultrasound imaging systems are further segmented into ophthalmic A-scan ultrasound, ophthalmic b-scan ultrasound, ophthalmic ultrasound biomicroscopes, and ophthalmic pachymeters.

On the basis of application, the market is segmented into glaucoma, amblyopia, cataract, retinal detachment, and others.

On the basis of end-user, the market is segmented into hospitals, ophthalmology clinics, diagnostic centers, research centers, and others.

Ophthalmic Equipment Market – Regional Analysis

The Americas dominates the global ophthalmic equipment market owing to the increasing prevalence of ophthalmic diseases and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for the market growth.

Europe is the second largest in the global ophthalmic equipment market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.  

Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/ophthalmic-equipment-market-5973

Asia Pacific is estimated to be the fastest growing market for ophthalmic equipment. This can be attributed to the presence of developing economies such as India and China and a huge patient population suffering from ophthalmic diseases. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.

On the other hand, the Middle East and Africa has the least share in the global ophthalmic equipment market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.

Major TOC For Ophthalmic Equipment Market Research Report – Forecast to 2023:

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective 

2.2.2 Assumptions

2.2.3 Limitations 

4 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

5 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

TOC Continued…!

Get Discount @ https://www.marketresearchfuture.com/check-discount/5973

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Negative Pressure Wound Therapy Market Highest Trend by 2023

Negative Pressure Wound Therapy Market – Synopsis

The global negative pressure wound therapy is predicted to register 6.7% CAGR during the forecast period (2018-2023) owing to the rising prevalence of chronic diseases, asserts Market Research Future (MRFR). NPWT, also known as negative-pressure wound therapy is referred to as a sealed wound-care system, majorly indicated for acute complicated wounds and large chronic persistent wounds. The system comprises a foam dressing and a controlled pump which drains out the wound. Negative pressure is applied around the wound which promotes healing. Such devices are used to manage chronic and acute wounds like venous ulcers, diabetic ulcers, pressure ulcers, arterial ulcers, and first- and second-degree burns. The therapy heals wound by applying vacuum through a sealed wound dressing. The vacuum further draws out the debris and fluid from the wound and helps to increases blood supply to the affected area.

Get sample Report at https://www.marketresearchfuture.com/sample_request/6514

Negative Pressure Wound Therapy Market – Competitive Dashboard

The prominent players operating the global negative pressure wound therapy market are Lohmann & Rauscher International GmbH & Co. Kg, Talley Group, Genadyne, Smith & Nephew, Medela, DeRoyal Industries Inc., Mölnlycke Health Care AB (A Subsidiary of Investor AB), ACELITY L. P. Inc., Cardinal Health, and ConvaTec Group Plc.

Negative Pressure Wound Therapy Market- Segmental Analysis

The global negative pressure wound therapy market has been segmented on the basis of wound type, product type, end-user, and region.

By mode of product type, the global negative pressure wound therapy market has been segmented into single-use negative pressure wound therapy devices, conventional negative pressure wound therapy devices, and accessories. Among these, the conventional segment is considered to account for the largest market share owing to the ability of conventional negative pressure wound therapy devices to manage severe wound exudates.

By mode of wound type, the global negative pressure wound therapy market has been segmented into ulcers, surgical and traumatic wounds, and burns. Among these, the ulcers segment has been further sub-segmented into venous ulcers, diabetic foot ulcers, pressure ulcers, and others. Surgical and traumatic wounds account for the largest market share owing to the increasing prevalence of such wounds coupled with an increasing spending on surgical and chronic wounds.

By mode of end-users, the global negative pressure wound therapy market has been segmented into home care settings, hospitals, and others. Among these, the hospitals segment is considered to account for the largest market share owing to the high number of surgeries performed in hospitals.

Drivers and Constraints Impacting the Market  

With rising prevalence of chronic diseases such as obesity and diabetes, increasing spending on surgical and chronic wounds, and growing causalities caused by accidents and trauma, the global negative pressure wound therapy is considered to propel during the forecast period. For instance, as per the Centers for Disease Control and Prevention, around 2.8 million people were hospitalized due to injuries in 2015. The augmenting rate of caesarean sections in elderly mothers is likely to accelerate the post-operative use of NPWT devices. Moreover, with the growing use of simplified single-use devices, the negative pressure wound therapy market is considered to propel during the forecast period. Additionally, the rise of hospitals with enhanced services for wound care is further anticipated to trigger the demand for NPWT across the globe.

On the flip side, the high cost associated with the therapy over conventional wound therapy coupled with a dearth of trained healthcare professionals are some of the major concerns anticipated to impede the market growth during the appraisal period. Also, absence of proof of clinical adequacy is predicted to restrict the market growth in the coming years.

Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/negative-pressure-wound-therapy-market-6514

Industry Updates 

December 07, 2018: An Acelity Company, KCI has recently announced the launch of the V.A.C.RX4 Therapy System in the United States. The V.A.C.RX4 System has been initially developed at the request of the U.S. Department of Defense and U.S. Air Force in order to help the military personnel treat multiple battlefield wounds with a single negative pressure wound therapy.

Negative Pressure Wound Therapy Market – Regional Insights

Geographically, the negative pressure wound therapy market span across regions namely, Europe, Americas, Asia-Pacific, and the Middle East and Africa.

Among all the regions, America is anticipated to dominate the global negative pressure wound therapy market. The growth is attributed to the presence of well-developed healthcare sector, augmenting rate of accidents, increasing prevalence of diabetes, and rising expenditure of the healthcare sector.

The European region is presumed to account for the second largest position owing to the increasing prevalence of chronic diseases and accelerating occurrences of burn cases and accidents. The Asia-Pacific region is anticipated to exhibit the fastest growth rate due to the presence of a huge population base of diabetic patients coupled with the rising developments in the healthcare segment.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Wearable Injectors Market Current Trend and Future Scope by 2023

Wearable Injectors Market – Overview

Market Research Future (MRFR) announces a new release on the global wearable injectors market. The report assesses the historical and present growth dynamics of the wearable injectors market in order to present a comprehensive view of the market’s growth prospects over the forecast period. The segmentation and competitive landscape of the global wearable injectors market have also been assessed in the market study in order to provide readers with a close overview of the various factors affecting the market’s movement on a granular level. The global wearable injectors market is expected to exhibit a CAGR of 15.2% over the forecast period (2018-2023).

Wearable injectors are devices used to deliver large dosages of medication directly into the patient’s body automatically. Wearable injectors can provide timely delivery of drug dosages without the patient having to ensure the periodicity of the drug delivery. Comparatively large dosages of various forms of medication can be easily delivered through wearable injectors, making them highly user-friendly and effective. The convenience of wearable injectors is likely to be the major driver for the global wearable injectors market over the forecast period.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/6491

The rising prevalence of diabetes and other chronic concerns is likely to be the major driver for the global wearable injectors market over the forecast period. Diabetes management is among the leading applications of wearable injectors, as delivering insulin via wearable injectors ensures regular delivery in the appropriate dosages.

Wearable Injectors Market – Competitive Analysis

Leading players in the global wearable injectors market include West Pharmaceutical Services Inc., Eli Lilly and Company, Amgen Inc., CeQur SA, Biospace, Sensile Medical AG, Enable Injections, SteadyMed Therapeutics Inc., Becton, Dickinson and Company, YPSOMED, and Valeritas Inc.

Wearable Injectors Market – Segmentation

The global wearable injectors market has been segmented on the basis of type, usage, mechanism of action, therapeutic area, and end user.

On the basis of type, the global wearable injectors market has been segmented into on-body wearable injectors, off-body wearable injectors, and hand-held wearable injectors.

The global wearable injectors market has been segmented by usage into disposable and semi-reusable wearable injectors.

By mechanism of action, the global wearable injectors market has been segmented into spring based, motor driven, rotary pump, expanding battery, pressurized gas, and collapsible reservoir.

By therapeutic area, the global wearable injectors market has been segmented into oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes, and others.

By end-user, the global wearable injectors market has been segmented into hospitals, clinics, homecare, ambulatory surgery centers, others.

Wearable Injectors Market – Regional Analysis                                                                       

The global wearable injectors market has been segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Browse Complete 100 Pages Premium Research Report Enabled with 98 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/wearable-injectors-market-6491

The Americas and Europe are likely to be the major contributors to the global wearable injectors market over the forecast period, primarily due to the growing prevalence of diabetes in these regions. Lifestyle factors in these regions have resulted in a growing prevalence of diabetes and other chronic diseases, as most of the population in these regions follows a sedentary lifestyle, which is highly conducive to the development of diabetes. The increasing consumption of fast food is also a major factor in the growing prevalence of diabetes in these two regions, and is likely to remain a major factor in the growth of the wearable injectors market over the forecast period. About a third of Europe’s population (above 15 years of age) suffers from a chronic disease, while nearly 20% of the population in the U.S. suffers from some autoimmune disease, which is also a key demand channel for the wearable injectors market (as of Q1 2017).

Asia Pacific is likely to exhibit the fastest growth over the forecast period in the global wearable injectors market. The key drivers for the wearable injectors market in Asia Pacific include the rising prevalence of diabetes and the growing awareness about advanced healthcare technologies, coupled with government and private-sector efforts to modernize the healthcare sector and bring in advanced technologies to fulfill the demands of the increasing urban and rural populace. Wearable injectors are still a novelty in most Asia Pacific countries, but are likely to increase in demand over the forecast period as customers get more used to the idea of wearable injectors and healthcare sector manufacturers make more efforts to bring in cheaper and more effective models.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers 

Magarpatta Road, Hadapsar,

Pune – 411028

Veterinary Surgical Instruments Market USD 2760.6 Mn Expected To Grow At CAGR 6.3% Forecasts To 2023

Global Veterinary Surgical Instruments Market Players

Eickemeyer Veterinary Equipment Inc.

Jørgen KRUUSE A/S

Surgical Holdings

Sklar Instruments

Whittemore Enterprises Inc.

Medtronics

B.Braun and others.

TRY PREMIUM SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/2785

Global Veterinary Surgical Instruments Market – Highlights

The global veterinary surgical instruments market has been evaluated as average growing market and is expected to witness higher single digit growth in coming years. The market has been extremely fragmented with a large number of players.

The industry of animal healthcare has seen strong technological advances in the last two decades. Most of these new tools and procedures have been adopted from human medical practice. These advanced technologies have not only led to better treatments, but also faster and precise diagnosis. From Ultrasounds and MRIs to the Amplatz Canine Ductal Occluder, there are various new technologies that are giving veterinary specialists a greater ability to diagnose and ultimately save sick animals globally. New technologies such as Magnetic resonance imaging, Ultrasounds, Laparoscopy, Microfracture detection, 3-D printing and Recombinant DNA.

While various veterinary technologies are likely to effect the industry in 2016, the biggest advancement is probable going to be the ability to print 3D objects, this rapid-prototyping procedure has been used by veterinary specialists to create animal bone models from information collected by computed tomography scans. This procedure not only helps veterinarians educate pet owners about their pet’s medical treatment or condition, but it also helps veterinary specialists to gain a solid understanding of a pets internal bone or muscle structure before going in to operate.

Global Veterinary Surgical Instruments Market – Segmentation

The global veterinary surgical instruments market is segmented on the basis of types. Based on the types, the market has been segmented as scalpel handles, forceps, dressing, scissors, needle holders and retractors. Based on the applications, the market has been segmented as orthopedic, sterilization, ophthalmic, dental. Based on the animals, the market has been segmented as canines, felines and large animals.

BROWSE PREMIUM RESEARCH REPORT @ https://www.marketresearchfuture.com/reports/veterinary-surgical-instruments-market-2785

Global Veterinary Surgical Instruments Market Regional Analysis

US accounts for the maximum market share due to favorable reimbursement scenario and the large and organized meat and dairy industry. Europe occupies the second position. The South American nations of Argentina, Paraguay, and Uruguay etc. also have large markets. However there is a definite shift of veterinary surgical instruments market to Asia pacific region. The Asia Pacific region will be led by China and India.

Table of Content Major Point by “Veterinary Surgical Instruments market research report – Global forecast to 2023”

1 Report Prologue

2 Introduction

3 Research Methodology

4 Market Factor Analysis

5 Market Dynamics

6 Global Veterinary Surgical Instruments Market by Types

7   Global Veterinary Surgical Instruments Market by Applications

8 Global Veterinary Surgical Instruments market by animals

9   Global Veterinary Surgical Instruments Market by Region

10 Competitive Landscape

11 Company Profile

12 List of Tables

13 List of Figures

GET EXCLUSIVE DISCOUNT @ https://www.marketresearchfuture.com/check-discount/2785

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Bone Cancer Market Top 11 Key Players Analysis and Forecasts Till 2022

Segments of Bone Cancer Market:

Bone cancer market has been segmented on the basis of types which comprises of multiple myeloma, osteosarcoma, chondrosarcoma, Ewing’s sarcoma and others. On the basis of treatments, market is segmented into chemotherapy, radiation therapy, cryosurgery, surgical treatments and others. On the basis of end user, market is segmented into hospital, clinic, cancer care centers and others.

Market Scenario of Bone Cancer Market:

Bone cancer occurs due to a formation of tumor, or abnormal mass of tissue in a bone. Primary bone cancers are the most serious type of all bone cancers. They form directly in the bones or surrounding tissue, such as cartilage. Globally the market for bone cancer is increasing rapidly. Globally the market for bone cancer is expected to grow at the rate of about XX% from 2016 to 2022.

Request Sample Report at https://www.marketresearchfuture.com/sample_request/1922

Key Players for Bone Cancer Market:

Some of the key players in this market are: AstraZeneca plc, Amgen, Inc., Actavis plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Co., F. Hoffmann-La Roche, GlaxoSmithKline plc, Novartis International AG, Pfizer Inc., Sanofi S.A. and others. 

Key Finding of Bone Cancer Market:

The bone cancer global market and is expected to reach $XX billion by 2022.

Chemotherapy holds the largest share of XX% of the market.

North America holds the largest market share of XX% of bone cancer market and is anticipated to reach $XX billion by the end of forecast period.

Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of XX% during the forecast period.

Chemotherapy holds the largest market share in 2015, and expected to continue the similar growth throughout the forecast period.

Regional Analysis of Bone Cancer Market:

Globally North America is the largest market for bone cancer. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for bone cancer.

Major TOC of Bone Cancer Market Research Report- Global Forecast to 2022

1 Report Prologue 

2 Market Introduction

2.1 Definition

2.2 Scope Of The Study 

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

….Continued TOC

Browse Complete 85 Pages Premium Research Report Enabled with 121 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/bone-cancer-market-1922

List of Tables

TABLE 1 GLOBAL BONE CANCER MARKET, BY TYPES, 2013-2022 (USD MILLION)

TABLE 2 GLOBAL BONE CANCER MARKET, BY TREATMENT, 2013-2022 (USD MILLION)

TABLE 3 GLOBAL BONE CANCER MARKET, BY END USER, 2013-2022 (USD MILLION)

TABLE 4 GLOBAL BONE CANCER MARKET, BY REGION, 2013-2022 (USD MILLION)

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL BONE CANCER MARKET, BY TYPES

FIGURE 4 GLOBAL BONE CANCER MARKET, BY TREATMENT

FIGURE 5 GLOBAL BONE CANCER MARKET, BY END USER

FIGURE 6 GLOBAL BONE CANCER MARKET, BY REGION

FIGURE 7 GLOBAL BONE CANCER MARKET: COMPANY SHARE ANALYSIS, 2015 (%)

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Microalbumin Test Market Registering CAGR ~ 13.5 % Expected by 2023

Major Players in Microalbumin test Market

Some of the key players in the global market are Beckman Coulter (U.S.), Siemens (Germany), Nova Biomedical (U.S.), Roche (Switzerland), Abbott (U.S.), URIT Medical (China), ARKRAY (Japan), OPTI Medical (U.S.), ACON Laboratories (US), Sysmex (Japan), 77 Elektronika (Hungary), and Randox Laboratories (U.K).

Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Microalbumin test market research report–Global forecast till 2023.”

Get Exclusive Sample Copy at https://www.marketresearchfuture.com/sample_request/5307

Microalbumin test Market – Highlights

Microalbumin test is one of the vital urine tests for the diagnosis of diabetes, kidney diseases, and diabetic retinopathy. Analyzer, reagent kit, control kit, micro-cuvettes, and test strips are various devices used in the microalbumin test. Hematuria (blood in the urine), certain medications, fever, vigorous exercise, urinary tract infection are some of the factors leading to the elevated levels of microalbumin in the urine.

The market is driven by the increasing prevalence of diabetes, renal dysfunction, and other kidney problems. In addition, increasing research and development activities, and technological advancements in medical device sector are fuelling the global microalbumin test market growth. The growth of the market is restricted by the accuracy and reliability of tests and the high cost of diagnostic devices. The global microalbumin test market is expected to grow at a CAGR of 5.1% during the forecast period.

Microalbumin test Market – Segmentation           

The global microalbumin test market is segmented on the basis of product, indication, and end user.

On the basis of the product, the market is segmented into analyzer, reagent kit, control kit, micro-cuvettes, test strips, and others.

On the basis of the indication, the market is segmented into kidney disease, diabetes, high blood pressure, and others.

On the basis of the end user, the market is segmented into hospitals, diagnostics laboratories, research laboratories, and others.

Microalbumin test Market – Regional Analysis 

The market for the microalbumin test is found to be increasing in the Americas. Extensive use of screening tests, availability of specialty services, and rising prevalence of kidney diseases is influencing the growth of the market. Additionally, increasing demand for technologically advanced diagnostic devices and presence of major market players are further driving the market growth. According to the Centre for Disease Control and Prevention (CDC), in 2014, nearly 118,000 people in the United States were treated for End-Stage Renal Disease (ESRD).

In Europe, extensive research and development activities on the medical devices, and extensive use of point-care-testing devices drive the market growth. Additionally, rising healthcare expenditure has also been a driving force for the market. According to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014, France recorded the second highest level of current healthcare expenditure of EUR 237 billion, followed by the U.K (EUR 223 billion). As per the article published in the Clinical Kidney Journal, the incidence of end-stage renal disease (ESRD) varies substantially between the countries in Europe. Furthermore, rising healthcare expenditure also impacts the market growth.

In Asia Pacific region, the increasing prevalence of diabetes, chronic kidney disease, and availability of diagnostic services are the driving factors for the growth of the market. India and China are major economies in the region having a high prevalence of diabetes, which is further expected to grow in the coming future. Additionally, availability of skilled healthcare professionals fuels the market growth.

Browse Complete 206 Pages Premium Research Report Enabled with 121 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/microalbumin-test-market-5307

In the Middle East & Africa, the increasing demand for specialty diagnostic services and developing healthcare system drive the growth of the market. In the Middle East, lack of physical exercise, and sedentary lifestyle are major factors responsible for diabetes and obesity, therefore, fuelling the market growth. In Africa, the demand for diagnosis and treatment of chronic diseases such as diabetes is found to be increasing, thus fuelling the market growth. As per the World Economic Forum, the prevalence of non-communicable, and chronic diseases are found to be increasing in the Middle East & Africa.

About US: 

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Refurbished Medical Devices Market Global Manufacturers Shares Innovations, Analysis and Forecasts to 2023

Key Players for Global Refurbished Medical Devices Market:

GE Healthcare (US), Stryker Corporation (US), Phillips Healthcare (Netherlands), Siemens Healthcare (Germany), Agito Medical (Denmark), DMS Topline (U.S.), Johnson & Johnson (US), First Source, Inc (U.S.), and Soma Technology (U.S.), Toshiba Medical System (Japan), Block Imaging International (US).

Refurbished medical devices are defined as the used medical devices which are restored by the manufacturer or other repairing expert into nearly original conditions. Increasing prevalence of cancer and other diseases has driven the growth of this market. Moreover, increasing privatization, presence of many low and medium budget hospitals and clinics and increasing demand for the refurbished medical devices due to its low cost also have a considerable impact of the growth of the market. While huge taxes on import of medical devices, lack of awareness regarding refurbished medical devices and unwillingness to pay for refurbished devices may restrain the growth of the market.

Get Sample Copy at https://www.marketresearchfuture.com/sample_request/1282

Refurbished Medical Devices Market Overview:

The Refurbished Medical Devices are defined as the used medical devices which are restored by the manufacturer or other repairing expert into nearly original conditions. Increasing prevalence of cancer and other diseases has driven the growth of this market.

Moreover, increasing privatization, presence of many low and medium budget hospitals and clinics and increasing demand for the refurbished medical devices due to its low cost also have a considerable impact of the growth of the market. While huge taxes on import of medical devices, lack of awareness regarding refurbished medical devices and unwillingness to pay for refurbished devices may restrain the growth of the market.

Refurbished Medical Devices Market Segmentation:  

Global refurbished medical devices market is segmented on the basis of diagnostic devices into patient monitors, X-Ray Machines, CT scanners, Ultrasound Systems, MRI machines, ECG systems, and other. On the basis of therapeutic devices the market is segmented in heart-lung machines, coagulation analyzers, infant incubators and warmers, defibrillators, infusion pumps and other.

Patients monitor devices covers the largest market share in global refurbished medical devices market on the basis of diagnosis. This is due to increasing awareness for chronic diseases and low product cost and technological advances in the patients monitoring devices.

Refurbished Medical Devices Market Regional Analysis:

On regional basis, global refurbished medical devices market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America commands the largest market for refurbished medical devices. Huge number of patient population, increasing aging population and cost containment issues related to healthcare budgets are the major reason for the growth of refurbished medical devices market in North America. Europe as the second largest market which is driven by increasing awareness about refurbished medical devices and poor reimbursement policies for new medical devices. Economic crises and low product cost has forced the people for adoption of refurbished medical devices. Asia Pacific is the fastest growing region for refurbished medical devices market. High cost of new medical devices and presence of number of low budget hospitals has led to increase this market in Asia Pacific region.

Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/refurbished-medical-devices-market-1282

Major Table of Content Refurbished Medical Devices Market Research Report- Global Forecast to 2023:

1. Report Prologue

2. Introduction


2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3 Research Methodology

1 Research Process

2 Primary Research

3 Secondary Research

4 Market Size Estimation

5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

TOC Continued…!

List of Tables

TABLE 1 REFURBISHED MEDICAL DEVICES MARKET BY TYPE

TABLE 2 REFURBISHED MEDICAL DEVICES MARKET BY TYPE OF MATERIAL

TABLE 3 REFURBISHED MEDICAL DEVICES MARKET BY END USER

TABLE 4 REFURBISHED MEDICAL DEVICES MARKET BY REGION

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 REFURBISHED MEDICAL DEVICES MARKET BY TYPE

FIGURE 4 REFURBISHED MEDICAL DEVICES MARKET BY TYPE OF MATERIAL

& More….!

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Rumination Syndrome Market Forecasts by Industry Drivers, Regions Till 2023

Rumination Syndrome Market Segmentation

The Global Rumination Syndrome Market is segmented by diagnosis, treatment, and end-user. The diagnosis segment is further sub-segmented into esophagogastroduodenoscopy, gastric emptying, and others. Furthermore, on the basis of treatment, the market is segmented into behavior therapy and medication. The medication segment has been sub-segmented into proton pump inhibitors and others. Proton pump inhibitors are sub-segmented into esomeprazole, omeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, and others. Based on end-user, the market is segmented into gastroenterology clinics, hospitals, research centers, and others.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American rumination syndrome market is segmented into two regions, namely, North America and South America. North America is further segmented into the U.S. and Canada. The European region includes both Eastern and Western European countries which are involved in the deployment of the rumination syndrome. Countries that are majorly involved in the rumination syndrome market are the U.K., France, Germany, Spain, and Italy, among others.

Get a Sample Report at https://www.marketresearchfuture.com/sample_request/6047

Rumination Syndrome Market Highlights

Gastrointestinal disorders cover a wide range of diseases. According to the WHO, approximately 6% of the total European population is suffering from GI disorders. Beside common diseases such as rumination syndrome, diarrhea, and chronic diseases such as celiac disease, diverticulitis, and irritable bowel syndrome help in contributing a huge share of the GI drug market. Factors such as increasing investments in research activities and growing population are responsible for the growth of the market in this region. Besides, this unhygienic food and improper diet are responsible for causing many GI disorders. Incorrect self-diagnosis and introduction of many misbranded and spurious drugs in the market are likely to be responsible for hampering the rumination syndrome market growth during the forecast period.

Key Players in the Global Rumination Syndrome Market

Pfizer Inc., Valent Pharmaceuticals, Medtronic, Astra Zeneca, Eisai Co. Ltd., Takeda Pharmaceuticals, Allergan Plc, Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Otsuka Pharmaceutical Co. Ltd, and others.

Regional Rumination Syndrome Market Summary:

According to MRFR analysis, North America holds the largest market and is mainly driven by the presence of major market players, high healthcare spending, and continuous technological development. Furthermore, established market players in the market lead to globalization by pushing new products and services into developing countries and emerging economies. South America is expected to be the fastest growing market for the American rumination syndrome market due to technologically advanced devices for diagnosis and increasing demand for treatment options of chronic diseases during the forecast period 2018–2023.

The European rumination syndrome market is expected to exhibit growth during the forecast period, 2018 to 2023 with an increasing emphasis on research and developmental activities for improvement in diagnosis and treatment methods. Moreover, Germany and the U.K. are the major contributors to the growth of the market. Additionally, increasing expenditure on healthcare by these countries in Europe also accelerates the growth of the market.

Asia Pacific is expected to grow at a faster pace during the forecast period, 2018–2023. The growth is majorly attributed to the increasing patient population in developing countries and increasing investments in the healthcare sector. For instance, India is experiencing high demand for GI and related disorder drugs. Moreover, major pharmaceutical drug manufacturers are using their technology and services to develop new drugs for GI diseases to meet the growing demand. Furthermore, healthcare in Malaysia is segmented into a government universal healthcare scheme and a private healthcare system. The private healthcare system is growing rapidly, especially, in urban areas due to increasing wealthy and middle-class population, geriatric population, urbanization, and high-quality healthcare and medicines. Thus, the rapidly growing economies of the Asia Pacific region are expected to provide vital support to the global rumination syndrome market.

The Middle Eastern and African market for the rumination syndrome exhibits a steady rise with an increase in the number of healthcare facilities providing treatments of chronic conditions and the flourishing growth of the medical devices market. In the African region, the awareness about the rumination syndrome is fueling the growth of the market. 

Browse Complete 100 Pages Premium Research Report Enabled with 79 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/rumination-syndrome-market-6047

Major Table of Contents for Rumination Syndrome Market Report Forecast To 2022:

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE

2   RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

TOC Continued…!

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Connect With us

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Page 2 of 29

Powered by WordPress & Theme by Anders Norén